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ElectroretinogramAbstract Background: Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous
group of inherited retinal degenerations that is estimated to affect more than 1.5 million people
worldwide. RP is characterized by retinal pigment deposits visible on fundus examination, abnor-
mal electroretinogram and progressive retinal dysfunction.
Aim: The present work aimed to identify the possible mutations in the rhodopsin gene (RHO)
among Egyptian RP patients as well as identifying the different inheritance patterns of those patients.
Subjects and methods: Thirty diagnosed retinitis pigmentosa patients were enrolled in the study.
Inheritance forms of RP were identiﬁed by recording full family history, the coding regions of the
rhodopsin gene were sequenced using blood-derived genomic DNA samples donated by patients
and ﬁfteen healthy controls.
Results: A high percentage of autosomal recessive cases was reported. Also a high parental
consanguinity rates were evident. Sequencing of rhodopsin gene revealed no mutations among the
study population.
Conclusion: Rhodopsin mutations are scarcely associated with the autosomal recessive RP,
suggesting that wide scale studies are needed to determine the genetic variations involved in RP
and particularly in the autosomal recessive inheritance.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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RP is the most common form of inherited retinopathies with a
wide variety in gene involvement, the frequency of RP is
approximately 1 in 3000 individuals [1,2]. To date up to 60
causative genes/loci have been identiﬁed in RP [24]. These
genes are involved in various metabolic pathways including
components of the photo-transduction cascade, proteins
involved in the retinoid cycle or photoreceptor structural
proteins [5,7,19].
Most genes for RP cause only a small proportion of cases,
with the exception of the rhodopsin gene (RHO), which
accounts for 25–30%, of autosomal dominant retinitis pigmen-
tosa (adRP) patients [3,17,18]. The rhodopsin protein is a pho-
ton detector for low luminance conditions as it is responsible
for the initiation of the visual transduction cascade upon the
incidence of a photon of light [6,20]. Rhodopsin is primarily
expressed in the rod photoreceptor cells, where it is packaged
into membranous disks located in the rod outer segment region
at high concentrations giving the rod cell a low threshold of
sensitivity of single photons of light [4,25].
Rhodopsin is considered the most mutant protein causing
the disorder with more than 100 different mutations
[1,25,30]. Genetic counseling is of major importance in order
to determine the inheritance pattern of the disorder and conse-
quently the underlying genetic cause. Most RHO mutations
are point mutations; Pro23His was the ﬁrst identiﬁed mutation
in adRP patients in North America but these point mutations
vary among different ethnic groups [12,17]. Furthermore,
many RHO mutations have been identiﬁed in only one family
[10]. Rhodopsin gene mutations may lead to protein misfold-
ing mediated neuro-degeneration either by causing misfolding
of the protein or by interfering with the normal trafﬁcking of
the protein to the photoreceptor outer segment [21,22].
This study aimed to identify the associated mutations in the
rhodopsin gene that leads to retinal degeneration in Egyptian
RP patients. This might help understanding the genetic causes
of photoreceptor degeneration, hoping to pave the way for
future therapeutic approachs.
2. Subjects and methods
2.1. Human subjects
Thirty patients with RP were diagnosed using established oph-
thalmologic criteria that are based on fundus examination and
electroretinogram (ERG). With the exception of patients with
syndromic forms, all referred patients with RP were enrolled in
this study regardless of the age of the onset. Fifteen controls
were also enrolled in the study. All patients and controls gave
their informed consent before participation in the study. We
have taken consent of the Ethics Committee of Cairo
University and the work has been carried out in accordance
with the Code of Ethics of the World Medical Association
(Declaration of Helsinki) for experiments in humans.
2.2. Genetic counseling
Patients were referred to the Ophthalmo-genetics Department,
Research Institute of ophthalmology. Thorough familyhistories were obtained from all patients and controls.
Family pedigrees were constructed and accordingly patients
were categorized either as sporadic where there is no other
affected family member or as autosomal dominant, autosomal
recessive or X-linked forms [9]. The criteria for autosomal
dominant transmission were either the presence of three or
more generations with both males and females among all
affected family members, or at least two affected generations
with male to male transmission [12,26]. For autosomal reces-
sive transmission the trait appears mainly in sibs much more
its appearance in parents or offspring. On average 25% of
the sibs of the proband are affected if both parents are carriers.
An autosomal recessive disorder is revealed by the appearance
of the disorder in the male and female progeny of unaffected
persons [29]. X-linked inheritance is characterized by expres-
sion of the trait by all males who carry the gene, but females
are affected only if they are homozygous. None of the sons
of an affected male are affected, but all his daughters are
carriers [9,29].
2.3. Extraction of genomic DNA
Genomic DNA was extracted from 300 ll of peripheral blood
lymphocytes using wizard genomic DNA extraction kit
(promega, USA) according to manufacturer’s protocol.
2.4. PCR
Exons of the RHO gene were ampliﬁed for each study subject
using 5 primer pairs (primer sequences are listed in Table 1) [8].
PCR was performed in a reaction volume of 25 ll containing
1 U Taq polymerase, 0.2 ll of each dNTP, 2.5 ll of PCR buf-
fer and 0.4 pmol/ll of each primer. A known volume of tem-
plate DNA was added depending on the sample DNA
concentration. On average, 4 ll of the template DNA was
used. The temperature cycle was an initial denaturation of
the DNA template at 94 C for 4 min, followed by denat-
uration during cycling at 94 C for 30 s for exons 1, 3, 5, for
45 s for exon 4, and for 1 min for exon 2. Annealing at
58 C was performed for 45 s for exon 4, for 30 s for exon 1,
and for 1 min for exon 2. Annealing for exons 5, 3 was per-
formed at 60 C for 30 s. Primer extension for all exons was
at 72 C for 1 min. Denaturation, annealing and extension
were repeated for 35 cycles in an automated thermocycler
(BIOER Technology Co. Ltd.). An aliquot of 3 ll of PCR
products was used to check the quality of the reaction products
by agarose gel electrophoresis.
2.5. Puriﬁcation of PCR products
QIAquick PCR puriﬁcation kit protocol (QIAGEN) was used
to purify DNA fragments from the PCR reaction. Three micro
liters of the puriﬁed DNA was used to test the quality of the
puriﬁed DNA by agarose gel electrophoresis.
2.6. Direct DNA sequencing
Puriﬁed PCR products were bi-directionally sequenced on an
automated ABI PRISM (310 Genetic Analyzer) sequencer
using ABI PRISM Big Dye terminator cycle sequencing ready
reaction kit (PE applied Biosystems, USA).
Table 1 PCR primers used for amplifying the rhodopsin gene.
Exon Primer sequence 50 to 30 Product size
(bp)
Exon 1 AGC TCA GGC CTT CGC AGC AT
GAG GGC TTT GGA TAA CAT TG
558
Exon 2 GAG TGC ACC CTC CTT AGG CA
TCC TGA CTG GAG GAC CCT AC
290
Exon 3 CTG TTC CCA AGT CCC TCA CA
CTG GAC CCT CAG AGC CGT GA
260
Exon 4 CAG CAT GCA TCT GCG GCT C
CCT GGG AAG TAG CTT GTC CTT
384
Exon 5 CAC TAA CGT GCC AGT TCC AAG C
TGA CTT CGT TCA TTC TGC ACA G
289
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3.1. Human subjects
Clinical diagnosis of RP patients was based on lesions in the
fundus and reduced ERG. Patients showed intra-retinalFigure 1 Flash ERG of RP patient. (A) Severely reduced scotopic re
ERG is rather less affected than scotopic responses.pigmentation and decreased visual acuity that deteriorated in
some patients to even no perception of light. Electroretino-
gram (ERG) represents the electrical response of the retina to
a light stimulus and is used for the diagnosis of various retinal
diseases. Dim ﬂash ERG is performed on a dark-adapted eye,
so the response is primarily from the rod system. Whereas ﬂash
ERG is performed on a light adapted eye and reﬂects the activ-
ity of the cone system [28]. Examination with ERG varied from
a reduction in rod and cone response amplitudes to even
undetected photoreceptor response (Fig. 1). Photopic ERG
(which measures the cone response) was rather less affected
than scotopic responses (which measure the rod response).
3.2. Genetic counseling
According to criteria mentioned in subjects and methods sec-
tion, patients were classiﬁed into 3 groups: eight were sporadic
(26.7%), ﬁve patients were autosomal dominant (16.6%) and
17 were autosomal recessive cases (56.7%). No case showed
X-linked inheritance. Consanguinity was evident in 20 cases
(66.6%); sixteen of them were autosomal recessive and four
were sporadic. Table 2 summarizes the characteristics of the
affected individuals.sponses, indicating markedly impaired rod function. (B) Photopic
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Rhodopsin exons were ampliﬁed using PCR. The PCR prod-
ucts showed well deﬁned bands. Direct forward and reverse
sequencing of the patients’ RHO exons revealed normal
sequences when compared to the gene bank sequence
(GenBank NT_005612.16).4. Discussion
Gene mapping and gene discovery have revealed that the
molecular genetic causes of RP are unusually complicated
especially in the autosomal recessive cases. Mutations in 22
different genes are associated with autosomal dominant RP
(adRP) [27,30], whereas over 30 genes and loci have been
implicated in autosomal recessive RP (arRP). Most of the
genes associated with arRP are rare, causing 1% or fewer cases
[30]. However, in the present study no mutations were detected
in the examined RHO gene. This may be attributed to the
high percentage of the autosomal recessive inheritance which
is the most prevalent inheritance pattern in Egypt [13]. The
high prevalence of recessive inheritance might be related to
the high parental consanguinity rates as consanguinity is
known to increase the frequency of recessive disorders [14].Table 2 Illustrates the personal data, inheritance forms and clinica
Patient ID Age Sex Age of diagnosis BCVA-RT
Code.1 33 M Adulthood 1/60
Code.2 51 M Adulthood 6/12
Code.3 38 M Adulthood 6/60
Code.4 33 M Adulthood 6/18
Code.5 32 M Childhood CF
Code.6 25 M Childhood 5/60
Code.7 23 F Adulthood 6/24
Code.8 55 F Adulthood No PL
Code.9 25 M Adulthood 2/60
Code.10 40 F Adulthood CF
Code.11 19 M Adulthood 1.5/60
Code.12 30 M Childhood 6/24
Code.13 17 F Adulthood 1/60
Code.14 32 M Childhood CF
Code.15 27 M Adulthood 1/60
Code.16 30 M Adulthood 5/60
Code.17 16 F Childhood 6/24
Code.18 53 M Childhood 2/60
Code.19 5 M Childhood HM
Code.20 47 F Adulthood 2/60
Code.21 46 F Adulthood 6/36
Code.22 6 F Childhood HM
Code.23 5 F Childhood 2/60
Code.24 31 M Childhood CF
Code.25 50 F Childhood CF
Code.26 52 M Adulthood 6/60
Code.27 47 M Adulthood No PL
Code.28 39 F Adulthood 3/60
Code.29 55 F Childhood 2/60
Code.30 32 M Adulthood 6/24
The table shows the sex, age of diagnosis, visual acuity, inheritance patte
pigmentosa; arRP; autosomal recessive retinitis pigmentosa; BCVA: best
eye; CF: count ﬁngers; HM: hand movements; PL: perception of light.Consanguineous marriage in Egypt is still high (35.3%) [15],
the parental consanguinity rates among RP patients were
much higher (71.4%) [13]. In the present study the parental
consanguinity rates were 66.6% of the study population.
Although there are over 100 mutations in the RHO gene
associated with RP identiﬁed in previous studies; only a few
of them are inherited with the autosomal recessive pattern
[30]. An up to date study aiming at determining the prevalence
of RHO mutations in adRP Spanish families found that RHO
mutations accounted for 21% of the study population, with
the most prevalent mutation Pro347Leu responsible for 4.5%
of all mutated adRP families [23].
Another study focused on the genetic heterogeneity of arRP
and studied the gene coding for the b-subunit of the rod phos-
phodiesterase (PDEB), rhodopsin, peripherin/RDS and the
gene coding the rod outer segment membrane protein 1
(ROM1) as well as two loci. Three homozygous mutations in
the PDEB gene were found, accounting for 6% of all cases.
No other disease-causing mutation was observed, suggesting
that it is unlikely that these genes and loci account for a con-
siderable proportion of arRP cases [31].
Also a previous study showed no mutation causing an
amino acid substitution of RHO in 68 Japanese patients with
RP [11]. In another attempt to identify RHO mutations associ-
ated with RP in Spain, thirty-six unrelated RP patients werel data of the patients.































rns and parental consanguinity. adRP: autosomal dominant retinitis
corrected visual acuity at time of examination; RT: right eye; LT: left
Rhodopsin mutations in retinitis pigmentosa 359screened for point mutations in the RHO gene. Neutral
variations were found, that do not represent a change in the
protein [16].
4.1. Conclusion
RHO gene mutations are very rare in autosomal recessive RP,
so that more patients need to be screened in future studies
keeping in mind that rhodopsin is not the only gene implicated
in RP, but a much more variety of genes are also involved and
need to be analyzed, especially in the autosomal recessive
form.
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